The preparation for the commencement of this P2 for GVHD with the FDA seems rigorous and exhausting!!
I can’t wait!
The can just got kicked down the road. Again.
Confirmation that they have more than enough funds to complete the P2 GVHD trial with the FDA. Totally outsourced (as per previous announcements) by the new leader.
Ok then.
I can’t wait. Still!
- Forums
- ASX - By Stock
- CYP
- Ann: Strategic Review of Cynata Clinical Development Portfolio
Ann: Strategic Review of Cynata Clinical Development Portfolio, page-15
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.0¢ |
Change
-0.005(1.82%) |
Mkt cap ! $48.78M |
Open | High | Low | Value | Volume |
27.5¢ | 28.5¢ | 26.5¢ | $71.17K | 257.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 145786 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 145786 | 0.270 |
3 | 12000 | 0.265 |
2 | 105000 | 0.260 |
3 | 14799 | 0.250 |
1 | 10000 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 15000 | 1 |
0.290 | 36000 | 1 |
0.295 | 25028 | 2 |
0.300 | 72500 | 2 |
0.305 | 29140 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |